Sale and Purchase of the Notes. 13 Section 2.01 Sale and Purchase of the Notes 13 Section 2.02 Closing 13 Section 2.03 Certain Funds Period 15 Section 2.04 Termination 16 ARTICLE III. REPRESENTATIONS AND WARRANTIES 17 Section 3.01 Representations and Warranties of the Company 17 Section 3.02 Representations and Warranties of each Purchaser 23 ARTICLE IV. ADDITIONAL AGREEMENTS 26 Section 4.01 Taking of Necessary Action 26 Section 4.02 Restricted Period; No Transfer 26 Section 4.03 Standstill 28 Section 4.04 Securities Laws 30 Section 4.05 Lost, Stolen, Destroyed or Mutilated Securities 30 Section 4.06 Antitrust & Foreign Investment Approval 31 Section 4.07 Board Nomination Rights; Committees 31 Section 4.08 Bid Management 36 Section 4.09 Financing Cooperation 37 Section 4.10 Certain Tax Matters 38 Section 4.11 Section 16 Matters 39 Section 4.12 D&O Indemnification / Insurance Priority Matters 39 Section 4.13 Conversion Price Matters 40 Section 4.14 Other Matters 40 Section 4.15 Indemnification 40 Section 4.16 Par Value 42 Section 4.17 Indenture Matters 42 Section 4.18 Conduct of Business 42 Section 4.19 Other Cooperation 42 Section 4.20 Use of Proceeds and Settlement of Target Shares 43 Section 4.21 Exchange Listing 43 Section 4.22 Anti-Takeover Provisions 43 Section 4.23 Board of Directors 43 Section 4.24 Convertibility 43 Section 4.25 Amendments 43 Section 4.26 Trustee 44 Section 4.27 Target Matters 44 ARTICLE V. REGISTRATION RIGHTS 44 Section 5.01 Registration Statement 44 Section 5.02 Registration Limitations and Obligations 45 Section 5.03 Company Registration 48 Section 5.04 Registration Procedures 48 Section 5.05 Expenses 51 Section 5.06 Registration Indemnification 51 Section 5.07 Facilitation of Sales Pursuant to Rule 144 54 Section 5.08 Other Registration Rights 54 ARTICLE VI. MISCELLANEOUS 54 Section 6.01 Survival of Representations and Warranties 54 Section 6.02 Notices 54 Section 6.03 Entire Agreement; Third Party Beneficiaries; Amendment 55 Section 6.04 Counterparts 56 Section 6.05 Public Announcements 56 Section 6.06 Expenses 56 Section 6.07 Successors and Assigns 56 Section 6.08 Governing Law; Jurisdiction; Waiver of Jury Trial 57 Section 6.09 Severability 58 Section 6.10 Specific Performance 58 Section 6.11 Headings 58 Section 6.12 Non-Recourse; Several Liability 58 Section 6.13 Competing Financing 59 Section 6.14 Non-Reliance 59 Section 6.15 Qualifying Spin-Off; Acquisition 60 Exhibit A: Form of Note Exhibit B: Form of Indenture Exhibit C: Form of Joinder Exhibit E: Co-operation Agreement Exhibit F: Signing Agreed Make-Whole Table Annex A: Plan of Distribution INVESTMENT AGREEMENT This INVESTMENT AGREEMENT (this “Agreement”), dated as of March 5, 2024 is by and between Viavi Solutions Inc., a Delaware corporation (together with any successor or assign pursuant to Section 6.07, the “Company”), SLP VII XX Xxxxxx Holdings, L.P. and SLA II XX Xxxxxx Holdings, L.P. (together with their successors and any respective Affiliates thereof that become a Purchaser party hereto in accordance with Section 6.07 and, if applicable, Section 4.02, each a “Purchaser” and, collectively, the “Purchasers”). Capitalized terms not otherwise defined where used shall have the meanings ascribed thereto in Article I.
Appears in 1 contract
Samples: Investment Agreement
Sale and Purchase of the Notes. 13 6 Section 2.01 Sale and Purchase of the Notes 13 6 Section 2.02 Closing 13 6 Section 2.03 Certain Funds Period 15 Section 2.04 Termination 16 8 ARTICLE III. REPRESENTATIONS AND WARRANTIES 17 8 Section 3.01 Representations and Warranties of the Company 17 8 Section 3.02 Representations and Warranties of each the Purchaser 23 16 Section 3.03 No Additional Representations 18 ARTICLE IV. ADDITIONAL AGREEMENTS 26 18 Section 4.01 Taking of Necessary Action 26 18 Section 4.02 Restricted Period; No Transfer 26 Shareholder Approval 18 Section 4.03 Standstill 28 Non-Disparagement 19 Section 4.04 Securities Laws 30 19 Section 4.05 Lost, Stolen, Destroyed or Mutilated Securities 30 Cooperation with Exchange 19 Section 4.06 Antitrust & Foreign Investment Approval 31 19 Section 4.07 Board Nomination Rights; Committees 31 Hedging 19 Section 4.08 Bid Management 36 Section 4.09 Financing Cooperation 37 Section 4.10 Certain Tax Matters 38 20 Section 4.11 4.09 [Reserved] 20 Section 16 Matters 39 Section 4.12 D&O 4.10 Indemnification / Insurance Priority Matters 39 Section 4.13 Conversion Price Matters 40 Section 4.14 Other Matters 40 Section 4.15 Indemnification 40 Section 4.16 Par Value 42 Section 4.17 Indenture Matters 42 Section 4.18 Conduct of Business 42 Section 4.19 Other Cooperation 42 Section 4.20 Use of Proceeds and Settlement of Target Shares 43 Section 4.21 Exchange Listing 43 Section 4.22 Anti-Takeover Provisions 43 Section 4.23 Board of Directors 43 Section 4.24 Convertibility 43 Section 4.25 Amendments 43 Section 4.26 Trustee 44 Section 4.27 Target Matters 44 20 ARTICLE V. REGISTRATION RIGHTS 44 21 Section 5.01 Registration Statement 44 21 Section 5.02 Registration Limitations and Obligations 45 22 Section 5.03 Company Registration 48 Procedures 23 Section 5.04 Registration Procedures 48 Expenses 25 Section 5.05 Expenses 51 Registration Indemnification 25 Section 5.06 Registration Indemnification 51 Section 5.07 Facilitation of Sales Pursuant to Rule 144 54 Section 5.08 Other Registration Rights 54 26 ARTICLE VI. MISCELLANEOUS 54 27 Section 6.01 Survival of Representations and Warranties 54 27 Section 6.02 Notices 54 27 Section 6.03 Entire Agreement; Third Party Beneficiaries; Amendment 55 27 Section 6.04 Counterparts 56 28 Section 6.05 Public Announcements 56 28 Section 6.06 Expenses 56 28 Section 6.07 Successors and Assigns 56 28 Section 6.08 Governing Law; Jurisdiction; Waiver of Jury Trial 57 28 Section 6.09 Severability 58 29 Section 6.10 Specific Performance 58 29 Section 6.11 Headings 58 29 Section 6.12 Non-Recourse; Several Liability 58 Section 6.13 Competing Financing 59 Section 6.14 Non-Reliance 59 Section 6.15 Qualifying Spin-Off; Acquisition 60 Exhibit A: Form of Note Exhibit B: Form of Indenture Exhibit C: Form of Joinder Exhibit E: Co-operation Agreement Exhibit F: Signing Agreed Make-Whole Table Annex A: Plan of Distribution INVESTMENT Recourse 29 PURCHASE AGREEMENT This INVESTMENT PURCHASE AGREEMENT (this “Agreement”), dated as of March 5January 9, 2024 2023 is by and between Viavi Solutions among 2U, Inc., a Delaware corporation (together with any successor or assign pursuant to Section 6.07, the “Company”), SLP VII XX Xxxxxx Holdings, L.P. and SLA II XX Xxxxxx Holdings, L.P. The Xxxx Family Trust (together with their successors and any respective Affiliates thereof that become a Purchaser party hereto in accordance with Section 6.07 and, if applicable, Section 4.02, each a the “Purchaser” and, collectively, the “Purchasers”). Capitalized terms not otherwise defined where used shall have the meanings ascribed thereto in Article I.
Appears in 1 contract
Samples: Purchase Agreement (2U, Inc.)
Sale and Purchase of the Notes. 13 10 Section 2.01 Sale and Purchase of the Notes 13 10 Section 2.02 Closing 13 10 Section 2.03 Certain Funds Period 15 Section 2.04 Termination 16 12 ARTICLE III. III REPRESENTATIONS AND WARRANTIES 17 12 Section 3.01 Representations and Warranties of the Company 17 12 Section 3.02 Representations and Warranties of each the Purchaser 23 18 ARTICLE IV. IV ADDITIONAL AGREEMENTS 26 21 Section 4.01 Taking of Necessary Action 26 21 Section 4.02 Restricted Period; No Transfer 26 Non-Conversion 21 Section 4.03 Standstill 28 23 Section 4.04 Securities Laws 30 26 Section 4.05 Lost, Stolen, Destroyed or Mutilated Securities 30 27 Section 4.06 Antitrust & Foreign Investment Approval 31 and Clearance 27 Section 4.07 Board Nomination Rights; Committees 27 Section 4.08 Financing Cooperation 31 Section 4.08 Bid Management 36 Section 4.09 Financing Cooperation 37 Section 4.10 Certain Tax Matters 38 32 Section 4.11 4.10 Section 16 Matters 39 32 Section 4.12 4.11 D&O Indemnification / Insurance Priority Matters 39 33 Section 4.13 4.12 Conversion Price Matters 40 33 Section 4.13 Voting 34 Section 4.14 Other Matters 40 Confidentiality 34 Section 4.15 Indemnification 40 NYSE Listing; WKSI Status 36 Section 4.16 Par Value 42 36 Section 4.17 Indenture Matters 42 Participation Rights 36 Section 4.18 Conduct Transfers of Business 42 Section 4.19 Other Cooperation 42 Section 4.20 Use of Proceeds and Settlement of Target Shares 43 Section 4.21 Exchange Listing 43 Section 4.22 Anti-Takeover Provisions 43 Section 4.23 Board of Directors 43 Section 4.24 Convertibility 43 Section 4.25 Amendments 43 Section 4.26 Trustee 44 Section 4.27 Target Matters 44 Purchaser Global Securities 38 ARTICLE V. V REGISTRATION RIGHTS 44 38 Section 5.01 Registration Statement 44 38 Section 5.02 Registration Limitations and Obligations 39 Section 5.03 Registration Procedures 41 Section 5.04 Expenses 45 Section 5.03 Company 5.05 Registration 48 Section 5.04 Registration Procedures 48 Section 5.05 Expenses 51 Indemnification 45 Section 5.06 Registration Indemnification 51 Section 5.07 Facilitation of Sales Pursuant to Rule 144 54 Section 5.08 Other Registration Rights 54 48 ARTICLE VI. VI MISCELLANEOUS 54 48 Section 6.01 Survival of Representations and Warranties 54 48 Section 6.02 Notices 54 48 Section 6.03 Entire Agreement; Third Party Beneficiaries; Amendment 55 49 Section 6.04 Counterparts 56 50 Section 6.05 Public Announcements 56 50 Section 6.06 Expenses 56 50 Section 6.07 Successors and Assigns 56 51 Section 6.08 Governing Law; Jurisdiction; Waiver of Jury Trial 57 51 Section 6.09 Severability 58 52 Section 6.10 Specific Performance 58 52 Section 6.11 Headings 58 52 Section 6.12 Non-Recourse; Several Liability 58 Recourse 52 Section 6.13 Competing Financing 59 Actions of Purchaser 53 Section 6.14 Non-Reliance 59 Section 6.15 Qualifying Spin-Off; Acquisition 60 Termination 53 Exhibit A: Form of Note Indenture Exhibit B: Form of Indenture Exhibit C: Form of Joinder Exhibit E: Co-operation Agreement Exhibit F: Signing Agreed Make-Whole Table Annex A: Plan of Distribution INVESTMENT AGREEMENT This INVESTMENT AGREEMENT (this “"Agreement”"), dated as of March 5June 14, 2024 2016, is by and between Viavi Solutions among Nu Skin Enterprises, Inc., a Delaware corporation (together with any successor or assign pursuant to Section 6.07, the “"Company”"), SLP VII XX Xxxxxx Holdingsand Ping An ZQ China Growth Opportunity Limited, L.P. and SLA II XX Xxxxxx Holdingsa Cayman Islands company limited by shares (the "Purchaser" and, L.P. (together with their its successors and any respective Affiliates thereof Affiliate that become becomes a Purchaser party hereto in accordance with Section 6.07 and, if applicable, 4.02 and Section 4.02, each a “Purchaser” and, collectively6.07, the “"Purchasers”"). Capitalized terms not otherwise defined where used shall have the meanings ascribed thereto in Article I.
Appears in 1 contract
Sale and Purchase of the Notes. 13 9 Section 2.01 2.1. Sale and Purchase of the Notes 13 Notes. 9 Section 2.02 2.2. Closing 13 Section 2.03 Certain Funds Period 15 Section 2.04 Termination 16 9 ARTICLE III. III REPRESENTATIONS AND WARRANTIES 17 11 Section 3.01 3.1. Representations and Warranties of the Company 17 11 Section 3.02 3.2. Representations and Warranties of each Purchaser the Investors. 17 ARTICLE IV COVENANTS 19 Section 4.1. Oversubscription. 19 Section 4.2. Exclusive Financing Right. 20 Section 4.3. Preferred Financing Partnership. 20 Section 4.4. Payment of Arrangement Fees. 21 Section 4.5. Governance Rights. 21 Section 4.6. Information Rights. 22 Section 4.7. Financing Cooperation. 22 Section 4.8. HKSE Listing 23 Section 4.9. Collateral Arrangement. 24 Section 4.10. Security Documents and Change in Law Event. 24 ARTICLE IV. V ADDITIONAL AGREEMENTS 26 25 Section 4.01 5.1. Taking of Necessary Action Action. 25 Section 5.2. Conduct of Business. 26 Section 4.02 Restricted Period; No Transfer 5.3. Use of Proceeds. 26 Section 4.03 Standstill 28 5.4. Securities Laws. 26 Section 4.04 Securities Laws 30 5.5. FPI Status. 27 Section 4.05 Lost, Stolen, Destroyed or Mutilated Securities 30 Section 4.06 Antitrust & Foreign Investment Approval 31 Section 4.07 Board Nomination Rights; Committees 31 Section 4.08 Bid Management 36 Section 4.09 Financing Cooperation 37 Section 4.10 Certain Tax Matters 38 Section 4.11 Section 16 Matters 39 Section 4.12 D&O Indemnification / Insurance Priority Matters 39 Section 4.13 5.6. Conversion Price Matters 40 27 Section 4.14 Other Matters 40 5.7. Termination of Covenants. 27 ARTICLE VI INDEMNIFICATION 27 Section 4.15 Indemnification 40 6.1. Indemnification. 27 Section 4.16 Par Value 42 6.2. Third Party Action. 28 ARTICLE VII MISCELLANEOUS 29 Section 4.17 Indenture Matters 42 7.1. Termination. 29 Section 4.18 Conduct 7.2. Effect of Business 42 Termination. 30 Section 4.19 Other Cooperation 42 7.3. Survival. 30 Section 4.20 Use of Proceeds and Settlement of Target Shares 43 7.4. Notices. 30 Section 4.21 Exchange Listing 43 Section 4.22 Anti-Takeover Provisions 43 Section 4.23 Board of Directors 43 Section 4.24 Convertibility 43 Section 4.25 Amendments 43 Section 4.26 Trustee 44 Section 4.27 Target Matters 44 ARTICLE V. REGISTRATION RIGHTS 44 Section 5.01 Registration Statement 44 Section 5.02 Registration Limitations and Obligations 45 Section 5.03 Company Registration 48 Section 5.04 Registration Procedures 48 Section 5.05 Expenses 51 Section 5.06 Registration Indemnification 51 Section 5.07 Facilitation of Sales Pursuant to Rule 144 54 Section 5.08 Other Registration Rights 54 ARTICLE VI7.5. MISCELLANEOUS 54 Section 6.01 Survival of Representations and Warranties 54 Section 6.02 Notices 54 Section 6.03 Entire Agreement; Third Party Beneficiaries; Amendment 55 Amendment. 31 Section 6.04 Counterparts 56 7.6. Counterparts. 32 Section 6.05 7.7. Confidentiality; Public Announcements 56 Announcements. 32 Section 6.06 Expenses 56 7.8. Expenses. 33 Section 6.07 7.9. Successors and Assigns 56 Assigns. 34 Section 6.08 7.10. Governing Law; Jurisdiction; Waiver of Jury Trial 57 Arbitration. 35 Section 6.09 7.11. Severability 58 35 Section 6.10 7.12. Specific Performance 58 Performance. 35 Section 6.11 7.13. Headings 58 36 Section 6.12 7.14. Non-Recourse; Several Liability 58 Section 6.13 Competing Financing 59 Section 6.14 Non-Reliance 59 Section 6.15 Qualifying Spin-Off; Acquisition 60 . 36 Schedule I: List of Investor Schedule II: Registration Rights Schedule III: Collateral Arrangements Schedule IV: 2025 Note Repurchase Exhibit A: Form of Note Indenture Exhibit B: Form of Indenture Exhibit C: Form of Joinder Exhibit E: Co-operation Agreement Exhibit F: Signing Agreed Make-Whole Table Annex A: Plan of Distribution INVESTMENT AGREEMENT This INVESTMENT AGREEMENT (this “Agreement”), dated as of March 5August 30, 2024 2022, is by and between Viavi Solutions Inc., a Delaware corporation (together with any successor or assign pursuant to Section 6.07, the “Company”), SLP VII XX Xxxxxx Holdings, L.P. and SLA II XX Xxxxxx Holdings, L.P. (together with their successors and any respective Affiliates thereof that become a Purchaser party hereto in accordance with Section 6.07 and, if applicable, Section 4.02, each a “Purchaser” and, collectively, the “Purchasers”). Capitalized terms not otherwise defined where used shall have the meanings ascribed thereto in Article I.among:
Appears in 1 contract
Samples: Investment Agreement (iQIYI, Inc.)